In conversation with...

Ke-Wu Zeng on molecular glues for cancer therapy

January 18, 2023 eBioMedicine
In conversation with...
Ke-Wu Zeng on molecular glues for cancer therapy
Show Notes

Drs Zeng join eBioMedicine to discuss their study of a novel molecular glue, called bufalin.

Read the full article:
Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy